AGMB-447
AGMB-447-C101
Phase 1 small_molecule active
Quick answer
AGMB-447 for IPF is a Phase 1 program (small_molecule) at Agomab Therapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Agomab Therapeutics NV
- Indication
- IPF
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active